CYTK

Cytokinetics, Incorporated News Headlines

$3.5
*  
0.05
1.45%
Get CYTK Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Genomic Health Reveals Positive Results - Analyst Blog
3/14/2013 5:47:59 PM - Zacks.com


Encouraging Results on ISIS Drug - Analyst Blog
3/14/2013 5:47:39 PM - Zacks.com


Loss at OREX Narrower than Expected - Analyst Blog
3/14/2013 5:45:16 PM - Zacks.com


Thermo Fisher Maintained at Neutral - Analyst Blog
3/14/2013 3:11:58 PM - Zacks.com


XOMA Posts Narrower Loss - Analyst Blog
3/14/2013 1:16:51 PM - Zacks.com


Lower Loss at Geron - Analyst Blog
3/14/2013 12:11:12 PM - Zacks.com


Peregrine Reports Narrower Loss - Analyst Blog
3/13/2013 6:14:18 PM - Zacks.com


Spectrum Guides Lower 2013 Revenue - Analyst Blog
3/13/2013 4:11:54 PM - Zacks.com


Biogen Files Hemophilia B Application - Analyst Blog
3/13/2013 4:09:18 PM - Zacks.com


Threshold Cuts Loss, Misses Sales - Analyst Blog
3/13/2013 9:10:16 AM - Zacks.com


Major Setback for Aeterna Zentaris - Analyst Blog
3/12/2013 7:13:03 PM - Zacks.com


PDLI Guides Q1 Royalty Revenue - Analyst Blog
3/12/2013 5:13:21 PM - Zacks.com


Update on Elan's Plans - Analyst Blog
3/11/2013 5:08:47 PM - Zacks.com


Acorda Presents GGF2 Data - Analyst Blog
3/8/2013 5:15:01 PM - Zacks.com


George Zavoico: Biotech Stocks That Deserve A Closer Look
3/8/2013 3:15:00 AM - Seeking Alpha


Elan to Share Tysabri Proceeds - Analyst Blog
3/7/2013 6:39:01 PM - Zacks.com


Takeda and Resolve Join Forces - Analyst Blog
3/7/2013 4:55:57 PM - Zacks.com


Narrower-Than-Expected Loss at OSIR - Analyst Blog
3/7/2013 9:30:01 AM - Zacks.com


Vertex Flu Drug Shows Promise - Analyst Blog
3/6/2013 1:20:01 PM - Zacks.com


PDLI Beats on Higher Revenues - Analyst Blog
3/6/2013 9:40:01 AM - Zacks.com


Standard Review for Biogen Drug - Analyst Blog
3/5/2013 4:50:01 PM - Zacks.com


JAZZ Beats EPS, Misses Sales - Analyst Blog
3/5/2013 2:19:01 PM - Zacks.com


Optimer Posts Wider Loss - Analyst Blog
3/4/2013 3:55:55 PM - Zacks.com


Affymax and Takeda Recall Drug - Analyst Blog
3/1/2013 5:50:01 PM - Zacks.com


Idenix Reports In-Line 4Q Loss - Analyst Blog
3/1/2013 11:08:01 AM - Zacks.com